PMAM
Picton Mahoney Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.7M | Buy |
332,369
+37,904
| +13% | +$4.07M | 0.37% | 38 |
|
|
2025
Q1 | $29.7M | Buy |
294,465
+13,344
| +5% | +$1.35M | 0.51% | 14 |
|
|
2024
Q4 | $25.1M | Sell |
281,121
-2,858
| -1% | -$255K | 0.51% | 15 |
|
|
2024
Q3 | $23.8M | Sell |
283,979
-4,239
| -1% | -$355K | 0.78% | 19 |
|
|
2024
Q2 | $22.2M | Sell |
288,218
-6,831
| -2% | -$526K | 0.86% | 18 |
|
|
2024
Q1 | $20.2M | Sell |
295,049
-2,993
| -1% | -$205K | 0.61% | 28 |
|
|
2023
Q4 | $17.2M | Buy |
298,042
+49,856
| +20% | +$2.88M | 0.47% | 36 |
|
|
2023
Q3 | $13.1M | Buy |
248,186
+89,323
| +56% | +$4.72M | 0.39% | 46 |
|
|
2023
Q2 | $8.59M | Buy |
158,863
+15,153
| +11% | +$820K | 0.37% | 82 |
|
|
2023
Q1 | $7.19M | Buy |
+143,710
| New | +$7.19M | 0.32% | 103 |
|
|
2017
Q1 | – | Sell |
-293,700
| Closed | -$6.35M | – | 180 |
|
|
2016
Q4 | $6.35M | Sell |
293,700
-64,270
| -18% | -$1.39M | 0.52% | 69 |
|
|
2016
Q3 | $8.52M | Sell |
357,970
-20,700
| -5% | -$493K | 0.57% | 64 |
|
|
2016
Q2 | $8.85M | Sell |
378,670
-19,400
| -5% | -$453K | 0.55% | 56 |
|
|
2016
Q1 | $7.49M | Sell |
398,070
-162,530
| -29% | -$3.06M | 0.48% | 75 |
|
|
2015
Q4 | $10.3M | Buy |
560,600
+5,700
| +1% | +$105K | 0.62% | 58 |
|
|
2015
Q3 | $9.11M | Sell |
554,900
-13,800
| -2% | -$226K | 0.53% | 67 |
|
|
2015
Q2 | $10.1M | Sell |
568,700
-467,500
| -45% | -$8.28M | 0.5% | 73 |
|
|
2015
Q1 | $18.4M | Sell |
1,036,200
-289,500
| -22% | -$5.14M | 0.7% | 35 |
|
|
2014
Q4 | $17.6M | Buy |
+1,325,700
| New | +$17.6M | 0.84% | 38 |
|
|
2013
Q3 | – | Sell |
-45,700
| Closed | -$424K | – | 330 |
|
|
2013
Q2 | $424K | Buy |
+45,700
| New | +$424K | 0.03% | 219 |
|